HQL / Abrdn Life Sciences Investors - Insider Trading and Ownership Report - SEC Form 3, 4, 5

Abrdn Life Sciences Investors
US ˙ NYSE ˙ US87911K1007

Insideraktier3.068.629 shares
Total Insiders16
Insider-stemningsscore

Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.

Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.

Officers sentiment score

Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.

Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.

Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.

Opdateringsfrekvens: Dagligt

Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.

Nøgle Insider Metrics

Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.

For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).

Netto antal insidere, der køber (rang)

0 ( )
677 out of 10916

Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).

Procent af float købt af insidere (rangering)

0.000% ( )
688 out of 10752

Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.

Insiderhandelsdiagram

Abrdn Life Sciences Investors insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.

Insiderliste og lønsomhedsmålinger

Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.

See our leaderboard of most profitable insider traders.

Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Michael W Bonney Director - [D] 2.388 2.388
Jeffrey Allen Bailey Director - [D] 580 580
Rose DiMartino Director - [D] 1.000 1.000
Kathleen Goetz Director - [D] 1.085 1.085
Thomas M Kent Director - [D] 1.300 1.300
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Bill Maher Director - [D] 1.715 1.715
Elizabeth G Nabel Director - [D] 5.574 5.574
Rebecca Suzanne Nichols - 0 0
Daniel R Omstead President, Director - [D] [O] 197.518 197.518
Oleg M Pohotsky Director - [D] 305 305
Insider Gennemsnitlig fortjeneste (%) Aktier
Ejet
Dele
Justeret
Christian Pittard Director - [D] 7.923 7.923
William S Reardon Director - [D] 1.612 1.612
Uwe E Reinhardt Director - [D] 3.010 3.010
Todd Reit Director - [D] 1.000 1.000
Lucinda H Stebbins Director - [D] 5.985 5.985
Saba Capital Management, L.P. 10% Owner - [10%] 2.837.633 2.837.633

Report errors via our new Insider Auditing Tool

Track Records af insiderkøb - Kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i HQL / Abrdn Life Sciences Investors. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2025-12-16 Pittard Christian 7.923 16,8818 7.923 16,8818 133.755 141 18.2200 10.603 7,93
2024-08-23 Maher Bill 650 15,3700 650 15,3700 9.990
2024-07-16 DiMartino Rose 1.000 15,5300 1.000 15,5300 15.530
2024-06-26 Saba Capital Management, L.P. 100 14,0700 100 14,0700 1.407
2024-06-24 Saba Capital Management, L.P. 13.812 14,0800 13.812 14,0800 194.473
2024-06-13 Saba Capital Management, L.P. 8.467 13,8200 8.467 13,8200 117.014
2024-06-12 Saba Capital Management, L.P. 2.400 13,8800 2.400 13,8800 33.312
2024-06-11 Saba Capital Management, L.P. 2.039 13,7600 2.039 13,7600 28.057
2024-06-10 Saba Capital Management, L.P. 9.704 13,7100 9.704 13,7100 133.042

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HQL / Abrdn Life Sciences Investors Insider Trades
Track Records af insidersalg - Kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i HQL / Abrdn Life Sciences Investors. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2025-09-22 Saba Capital Management, L.P. 41.623 14,1400 41.623 14,1400 588.549 1 14.1100 -1.248 -0,21
2025-09-19 Saba Capital Management, L.P. 6.989 14,1000 6.989 14,1000 98.545
2025-09-18 Saba Capital Management, L.P. 40.208 14,0700 40.208 14,0700 565.727
2025-09-17 Saba Capital Management, L.P. 24.328 13,9900 24.328 13,9900 340.349
2025-09-16 Saba Capital Management, L.P. 2.026 13,9900 2.026 13,9900 28.344
2025-09-15 Saba Capital Management, L.P. 700 14,1300 700 14,1300 9.891
2025-09-11 Saba Capital Management, L.P. 15.116 14,2800 15.116 14,2800 215.856
2025-09-02 Saba Capital Management, L.P. 14.083 14,0400 14.083 14,0400 197.725
2025-08-29 Saba Capital Management, L.P. 23.723 13,8900 23.723 13,8900 329.512

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

HQL / Abrdn Life Sciences Investors Insider Trades
Transaktionshistorik

Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.

Fil
Dato
Handle
Dato
Form Insider Ticker Sikkerhedstitel Kode 10b5-1 Direkte Dyrke motion
Pris
Enhed
Pris
Enheder
Ændret
Værdi
Ændret (1K)
Tilbage
Muligheder
Tilbage
Aktier
2025-12-18 2025-12-16 4 Pittard Christian HQL Common Stock P - Purchase D 16,8818 7.923 134 7.923
2025-09-23 2025-09-22 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,1400 -41.623 -589 2.837.633
2025-09-23 2025-09-19 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,1000 -6.989 -99 2.879.256
2025-09-19 2025-09-18 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,0700 -40.208 -566 2.886.245
2025-09-19 2025-09-17 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,9900 -24.328 -340 2.926.453
2025-09-17 2025-09-16 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,9900 -2.026 -28 2.950.781
2025-09-17 2025-09-15 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,1300 -700 -10 2.952.807
2025-09-15 2025-09-11 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,2800 -15.116 -216 2.953.507
2025-09-04 2025-09-02 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,0400 -14.083 -198 2.968.623
2025-09-02 2025-08-29 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,8900 -23.723 -330 2.982.706
2025-08-27 2025-08-26 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,8300 -400 -6 3.006.429
2025-08-25 2025-08-21 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,0700 -10.710 -151 3.006.829
2025-05-22 2025-05-20 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,7100 -11.419 -145 3.017.539
2025-05-19 2025-05-15 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,0800 -23.729 -287 3.028.958
2025-05-15 2025-05-14 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,0400 -600 -7 3.052.687
2025-05-15 2025-05-13 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,2800 -730 -9 3.053.287
2025-05-12 2025-05-08 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11,9800 -12.689 -152 3.054.017
2025-05-08 2025-05-07 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,1900 -1.366 -17 3.066.706
2025-04-21 2025-04-17 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11,7800 -9.144 -108 3.068.072
2025-04-17 2025-04-15 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11,9200 -1.700 -20 3.077.216
2025-04-15 2025-04-14 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11,6700 -15.400 -180 3.078.916
2025-04-14 2025-04-10 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11,1400 -30.156 -336 3.094.316
2025-04-07 2025-04-04 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 11,5700 -6.889 -80 3.124.472
2025-04-07 2025-04-03 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,2300 -10.321 -126 3.131.361
2025-04-03 2025-04-02 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,2800 -29.102 -357 3.141.682
2025-04-03 2025-04-01 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,4500 -17.621 -219 3.170.784
2025-04-01 2025-03-31 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,5800 -48.623 -612 3.188.405
2025-03-31 2025-03-28 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 12,9500 -3.602 -47 3.237.028
2025-03-31 2025-03-27 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,0100 -32.922 -428 3.240.630
2025-03-25 2025-03-24 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,2100 -2.329 -31 3.273.552
2025-02-27 2025-02-26 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,6200 -200 -3 3.275.881
2025-02-18 2025-02-13 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,8800 -100 -1 3.276.081
2025-02-13 2025-02-12 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,7500 -36.536 -502 3.276.181
2025-02-12 2025-02-11 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,7700 -19.756 -272 3.312.717
2025-02-12 2025-02-10 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 13,9500 -42.987 -600 3.332.473
2025-02-05 2025-02-04 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,0500 -4.065 -57 3.375.460
2025-02-05 2025-02-03 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,0300 -1.846 -26 3.379.525
2025-02-03 2025-01-31 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,2700 -15.143 -216 3.381.371
2025-02-03 2025-01-30 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,1600 -21.835 -309 3.396.514
2025-01-30 2025-01-29 4 Saba Capital Management, L.P. - HQL Common Stock S - Sale I 14,1200 -11.674 -165 3.418.349
2024-08-27 2024-08-23 4 Maher Bill By Spouse HQL Common Stock P - Purchase I 15,3700 650 10 1.715
2024-07-18 2024-07-16 4 DiMartino Rose HQL Common Stock P - Purchase D 15,5300 1.000 16 1.000
2024-06-27 2024-06-26 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 14,0700 100 1 3.429.991
2024-06-25 2024-06-24 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 14,0800 13.812 194 3.429.891
2024-06-18 3 Nichols Rebecca Suzanne HQL Common Shares D 0
2024-06-14 2024-06-13 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,8200 8.467 117 3.416.079
2024-06-14 2024-06-12 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,8800 2.400 33 3.407.612
2024-06-11 2024-06-11 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,7600 2.039 28 3.405.212
2024-06-11 2024-06-10 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,7100 9.704 133 3.403.173
2024-06-10 2024-06-07 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,7200 3.763 52 3.393.469
2024-06-10 2024-06-06 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,8000 9.598 132 3.389.706
2024-06-05 2024-06-05 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,7600 26.083 359 3.380.108
2024-06-05 2024-06-04 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,5000 33.357 450 3.354.025
2024-06-03 2024-05-31 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,2900 21.369 284 3.320.668
2024-05-31 2024-05-30 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,0500 669 9 3.299.299
2024-05-31 2024-05-29 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,0900 38.033 498 3.298.630
2024-05-31 2024-05-28 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,3800 8.714 117 3.260.597
2024-05-23 2024-05-23 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,5000 1.303 18 3.251.883
2024-05-17 2024-05-15 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 14,1900 34.755 493 3.250.580
2024-05-14 2024-05-10 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,8600 57.862 802 3.215.825
2024-05-10 2024-05-09 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,8000 17.373 240 3.157.963
2024-05-10 2024-05-08 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,7000 10.986 151 3.140.590
2024-05-07 2024-05-07 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,7600 50.161 690 3.129.604
2024-05-07 2024-05-06 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,6200 10.713 146 3.079.443
2024-05-02 2024-05-02 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,4600 26.274 354 3.068.730
2024-05-02 2024-05-01 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,0200 252 3 3.042.456
2024-05-01 2024-04-30 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,1300 16.573 218 3.042.204
2024-04-29 2024-04-26 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,0000 120.304 1.564 3.025.602
2024-04-26 2024-04-25 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 12,9900 97.574 1.267 2.905.298
2024-04-26 2024-04-24 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,1200 20.529 269 2.807.724
2024-04-23 2024-04-23 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 13,1500 48.203 634 2.787.195
2024-04-23 2024-04-22 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 12,8800 2.022 26 2.738.992
2024-04-22 2024-04-19 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 12,8400 42.459 545 2.736.970
2024-04-22 2024-04-18 4 Saba Capital Management, L.P. - HQL Common Stock P - Purchase I 12,8000 81.738 1.046 2.694.511
2024-04-19 3 Saba Capital Management, L.P. - HQL Common Stock I 2.694.511
2024-04-12 2024-04-09 4 Goetz Kathleen HQL Common Stock P - Purchase D 13,3183 400 5 1.085
2024-01-04 2024-01-02 4 Reit Todd HQL Common Stock P - Purchase D 13,7980 1.000 14 1.000
2024-01-02 2023-12-28 4 Maher Bill HQL Common Stock P - Purchase D 13,5700 1.000 14 1.000
2023-09-25 2023-09-25 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 12,3926 10.096 125 197.518
2023-09-20 2023-09-20 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 12,6838 12.000 152 187.422
2022-03-24 2022-03-23 4 Goetz Kathleen HQL Shares of Beneficial Interest P - Purchase D 16,2700 92 2 685
2022-01-27 2022-01-26 4 Goetz Kathleen HQL Shares of Beneficial Interest P - Purchase D 17,5441 593 10 593
2021-08-12 2021-08-11 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 21,6300 6.403 138 146.489
2020-10-26 2020-10-26 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 17,5229 6.175 108 131.836
2020-10-21 2020-10-21 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 17,7489 5.950 106 125.661
2020-09-23 2020-09-22 4 Bailey Jeffrey Allen HQL Shares of Beneficial Interest P - Purchase D 17,2800 580 10 580
2020-05-22 2020-05-21 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 17,7406 5.950 106 114.821
2020-03-17 2020-03-17 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 13,2659 8.300 110 105.814
2018-12-19 3 NABEL ELIZABETH G HQL Shares of Beneficial Interest D 5.574
2018-12-19 3 NABEL ELIZABETH G HQL Shares of Beneficial Interest D 5.574
2018-12-19 3 NABEL ELIZABETH G HQL Shares of Beneficial Interest D 5.574
2018-01-29 2018-01-25 4 Kent Thomas M HQL Shares of Beneficial Interest P - Purchase D 21,0369 1.300 27 1.300
2015-06-29 2015-06-29 4 STEBBINS LUCINDA H HQL Shares of Beneficial Interest P - Purchase D 28,1700 -1.000 -28 5.985
2014-07-11 2014-06-24 4 REINHARDT UWE E HQL Subscription Rights X - Other D 19,75 -2.256 0
2014-07-11 2014-06-24 4 REINHARDT UWE E HQL Shares of Beneficial Interest X - Other D 19,7500 752 15 3.010
2014-07-01 2014-06-24 4 OMSTEAD DANIEL R HQL Subscription Rights X - Other D 19,75 -44.064 0
2014-07-01 2014-06-24 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest X - Other D 19,7500 14.688 290 58.757
2014-07-01 2014-06-30 4 REARDON WILLIAM S HQL Shares of Beneficial Interest P - Purchase D 19,7500 200 4 1.612
2014-06-30 2014-06-24 4 BONNEY MICHAEL W HQL Subscription Rights X - Other D 19,75 -2.077 0
2014-06-30 2014-06-24 4 BONNEY MICHAEL W HQL Shares of Beneficial Interest X - Other D 19,7500 1.459 29 2.388
2014-06-30 2014-06-24 4 POHOTSKY OLEG M HQL Subscription Rights X - Other D 19,75 -228 0
2014-06-30 2014-06-24 4 POHOTSKY OLEG M HQL Shares of Beneficial Interest X - Other D 19,7500 76 2 305
2014-06-30 2014-06-24 4 REARDON WILLIAM S HQL Subscription Rights X - Other D 19,75 -1.134 0
2014-06-30 2014-06-24 4 REARDON WILLIAM S HQL Shares of Beneficial Interest X - Other D 19,7500 578 11 1.412
2014-06-30 2014-06-24 4 STEBBINS LUCINDA H HQL Subscription Rights X - Other D 19,75 -3.000 0
2014-06-30 2014-06-24 4 STEBBINS LUCINDA H HQL Shares of Beneficial Interest X - Other D 19,7500 1.000 20 6.985
2013-06-04 2013-06-04 4 OMSTEAD DANIEL R HQL Shares of Beneficial Interest P - Purchase D 17,5789 6.000 105 40.980
2012-03-21 2012-03-19 4 POHOTSKY OLEG M HQL Shares of beneficial interest P - Purchase D 13,2999 200 3 200
2012-03-12 2012-03-09 4 BONNEY MICHAEL W HQL Shares of Beneficial Interest P - Purchase D 13,2546 800 11 800
2012-03-12 2012-03-09 4 REARDON WILLIAM S HQL Shares of Beneficial Interest P - Purchase D 13,2660 772 10 772
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista